001     144578
005     20220601114153.0
024 7 _ |a 10.1007/978-1-4614-1025-6_43
|2 doi
037 _ _ |a DZNE-2020-00090
100 1 _ |a Hatfield, Dolph L.
|0 P:(DE-HGF)0
|b 0
|e Editor
245 _ _ |a Mouse Models for Glutathione Peroxidase 4 (GPx4)
260 _ _ |a New York, NY
|c 2012
|b Springer New York
295 1 0 |a Selenium / Hatfield, Dolph L. (Editor) ; New York, NY : Springer New York, 2012, Chapter 43 ; ISBN: 978-1-4614-1024-9 ; doi:10.1007/978-1-4614-1025-6
300 _ _ |a 547-559
336 7 _ |a BOOK_CHAPTER
|2 ORCID
336 7 _ |a Book Section
|0 7
|2 EndNote
336 7 _ |a bookPart
|2 DRIVER
336 7 _ |a INBOOK
|2 BibTeX
336 7 _ |a Output Types/Book chapter
|2 DataCite
336 7 _ |a Contribution to a book
|b contb
|m contb
|0 PUB:(DE-HGF)7
|s 1654076492_17981
|2 PUB:(DE-HGF)
520 _ _ |a The selenoperoxidase glutathione peroxidase 4 (GPx4 – also frequently referred to as phospholipid hydroperoxide glutathione peroxidase, PHGPx) is one of the eight glutathione peroxidases in mammals, but the only one known to be essential for early mouse development. GPx4 is emerging as one of the most central selenoproteins, and thus has attracted considerable interest in recent years. Key insights into GPx4 function came from the numerous transgenic and knockout mouse studies performed mainly during the last couple of years, which are summarized here. These investigations not only firmly established a crucial role for GPx4 in male fertility and neuroprotection, but also indicated a major regulatory role of GPx4 in oxidative stress-induced cell death signaling. Beyond this, lipid hydroperoxides (LOOH), downstream of GPx4 inactivation, have been recently shown to control receptor tyrosine kinase (RTK) signaling, thus adding a new layer of complexity to the multifaceted roles of GPx4 in cell signaling and disease development.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef Book
700 1 _ |a Berry, Marla J.
|0 P:(DE-HGF)0
|b 1
|e Editor
700 1 _ |a Gladyshev, Vadim N.
|0 P:(DE-HGF)0
|b 2
|e Editor
700 1 _ |a Conrad, Marcus
|0 P:(DE-2719)2369795
|b 3
|e First author
|u dzne
773 _ _ |a 10.1007/978-1-4614-1025-6_43
909 C O |p VDB
|o oai:pub.dzne.de:144578
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2369795
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2012
920 1 _ |0 I:(DE-2719)1140001
|k AG Wurst
|l Genome Engineering
|x 0
980 _ _ |a contb
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1140001
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21